Paper Review Records
全部论文审稿周期
12 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期；保留 PDF/DOI/网页源链接
189
天
RNA editing of pathogenic variants causing inherited retinal diseases using endogenous ADAR-current and future perspectives
作者
Manar Salameh; Nina Schneider; Johanna Valensi; Asodu Sandeep Sarma; Erez Y. Levanon; Shay Ben-Aroya; Dror Sharon展开收起
作者单位
Department of Ophthalmology, Hadassah Medical Center, Faculty of Medicine, The Hebrew University of Jerusalem, 91120, Israel; The Mina and Everard Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat-Gan, 5290002, Israel展开收起
62
天
Advancing precision medicine in pancreatic cancer using novel biomarkers and clinical targets
作者
Divya Murthy; Attila A. Seyhan; Petra den Hollander; Shaolei Lu; Nick A. Kuburich; Claire Gould; Andrew A. Karam; Katie Sun; Patrick G. Schupp; Howard Safran; Razelle Kurzrock; Wafik El-Deiry; Sendurai A. Mani展开收起
作者单位
Legorreta Cancer Center, Warren Alpert Medical School, Brown University, Providence, RI, United States; Department of Pathology and Laboratory Medicine, Warren Alpert Medical School, Brown University, Providence, RI, United States; Joint Program in Cancer Biology, Brown University Health and Brown University, Providence, RI, United States; Laboratory of Translational Oncology and Experimental Cancer Therapeutics, Warren Alpert Medical School, Brown University, Providence, RI, United States; Hematology/Oncology Division, Department of Medicine, Brown University Health and Brown University, Providence, RI, United States; Division of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin and the LaBahn Pancreatic Cancer Program, Milwaukee, WI, United States; Department of Medicine, Warren Alpert Medical School, Brown University, Providence, RI, United States展开收起
166
天
248
天
Dual-targeting strategies for cancer and diabetes: Converging pharmacological pathways and repurposed therapies
作者
Gurjit Kaur Bhatti; Ishtiaq Ahmed; Abhishek Sehrawat; Pushpender Kumar Sharma; Ramesh Kandimalla; Kawaljit Singh Kaura; Jasvinder Singh Bhatti展开收起
作者单位
Department of Medical Lab Technology, University Institute of Allied Health Sciences, Chandigarh University, Mohali, 140413, Punjab, India; University Centre for Research and Development, Chandigarh University, Mohali, 140413, Punjab, India; Laboratory of Translational Medicine and Nanotherapeutics, Department of Human Genetics and Molecular Medicine, School of Health Sciences, Central University of Punjab, Bathinda, India; Amity Institute of Biotechnology, Amity University Rajasthan, Jaipur, 303002, India; Amity Center of Nanobiotechnology and Nanomedicine, Amity University Rajasthan, Jaipur, India; Department of Biochemistry, Kakatiya Medical College, Warangal, India; Department of Urology, All India Institute of Medical Sciences, Bathinda, Punjab, India展开收起
186
天
Metabolic dysregulation: Its role in diabetes mellitus and cancers
作者
Shuang Dai; Jiacheng Li; Jing Xia; Yingtong Liu; Yan Li展开收起
作者单位
Health and Management Center, General Practice Medical Center, West China Hospital, Sichuan University, Chengdu, China; College of Medical and Life Sciences, Chengdu University of Traditional Chinese Medicine, Chengdu, China; Lung Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China; Department of Radiation Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China展开收起
31
天
Viral triggers and genetic predisposition in ocular autoimmunity: unraveling the breakdown of immune privilege and advancing targeted therapeutics
作者
Jianhao Bai; Zhiyong Wu; Zhongqi Wan; Chun Zhao; Yin Liu; Tianyu Wang展开收起
作者单位
Department of Ophthalmology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China; Shanghai Heping Eye Hospital, Shanghai, China; Department of Ophthalmology, Shanghai Tenth People's Hospital Affiliated to Tongji University, Tongji University School of Medicine, Shanghai, China; Department of Ophthalmology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China; Ningbo Key Laboratory of Medical Research on Blinding Eye Diseases, Ningbo Eye Institute, Ningbo Eye Hospital, Wenzhou Medical University, Ningbo, 315040, China展开收起
Expert Matching · Case Demo
把投稿要求，转成可验证的期刊方案
说清专业、时限和作者背景，CrushSCI 结合真实审稿样本，给出拟题方向、期刊初筛与周期判断。
客户询问
我是环境工程专业，需要一篇 SCI，希望 3 个月内见刊。没有基金，也没有大牛挂名，可以投哪些期刊？
CrushSCI回复
可以。先按 90 天时限做可行性筛选，同步查找无基金、无知名作者挂靠的典型论文案例，作为选刊依据。重点核对研究质量与期刊 scope。
- 拟题建议
- 《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》
样本口径2026 年最近 5 篇有效论文样本
平均审稿62 天
中位数65 天